Cargando…

Proteomics insights into the pathology and prognosis of chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) is an incurable malignant disease of B-lymphocytes characterized by drastically heterogeneous clinical courses. Proteomics is an advanced approach that allows a global profiling of protein expression, providing a valuable chance for the discovery of disease-related...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alsagaby, Suliman A., Alhumaydhi, Fahad A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Saudi Medical Journal 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506661/ https://www.ncbi.nlm.nih.gov/pubmed/30957124 http://dx.doi.org/10.15537/smj.2019.4.23598

Ejemplares similares

Transcriptomics-based validation of the relatedness of heterogeneous nuclear ribonucleoproteins to chronic lymphocytic leukemia as potential biomarkers of the disease aggressiveness
por: Alsagaby, Suliman A.
Publicado: (2019)

Omics-based insights into therapy failure of pediatric B-lineage acute lymphoblastic leukemia
por: Alsagaby, Suliman A.
Publicado: (2019)

In silico investigations identified Butyl Xanalterate to competently target CK2α (CSNK2A1) for therapy of chronic lymphocytic leukemia
por: Alsagaby, Suliman A., et al.
Publicado: (2022)

Mechanistic Insight into the Binding of Huperzine a with Human Transferrin: Computational, Spectroscopic and Calorimetric Approaches
por: Atiya, Akhtar, et al.
Publicado: (2022)

Mechanistic Insight into Binding of Huperzine A with Human Serum Albumin: Computational and Spectroscopic Approaches
por: Shamsi, Anas, et al.
Publicado: (2022)

Molecular Insights into the Potential of Extracellular Vesicles Released from Mesenchymal Stem Cells and Other Cells in the Therapy of Hematologic Malignancies
por: Alsagaby, Suliman A.
Publicado: (2021)

Transcriptomics-Based Characterization of the Toxicity of ZnO Nanoparticles Against Chronic Myeloid Leukemia Cells
por: Alsagaby, Suliman A, et al.
Publicado: (2020)

Prognosis Factors in Chronic Lymphocytic Leukemia
por: Ivanescu, AM, et al.
Publicado: (2012)

Risk factors of SARS-CoV-2 infection in cancer patients pre- and post-vaccination
por: Alsagaby, Suliman A., et al.
Publicado: (2022)

Inhibitory Potential of the Ocimum sanctum Phytochemicals on Bruton’s Tyrosine Kinase, a Well-Known Drug Target for Treatment of Chronic Lymphocytic Leukemia: An In Silico Investigation
por: Mir, Shabir Ahmad, et al.
Publicado: (2023)

The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment
por: Pérez-Carretero, Claudia, et al.
Publicado: (2021)

Elucidating the Interactions of Fluoxetine with Human Transferrin Employing Spectroscopic, Calorimetric, and In Silico Approaches: Implications of a Potent Alzheimer’s Drug
por: Khan, Mohd Shahnawaz, et al.
Publicado: (2022)

Pathology of Seminoma Coinciding With Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia
por: Bui, Katherine M, et al.
Publicado: (2021)

Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia
por: Vitale, Candida, et al.
Publicado: (2021)

Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia: New Insights into Leukemic Progression
por: Prieto, Daniel, et al.
Publicado: (2017)

Bioactive Phytoconstituents as Potent Inhibitors of Tyrosine-Protein Kinase Yes (YES1): Implications in Anticancer Therapeutics
por: Yang, Chunmin, et al.
Publicado: (2022)

A comprehensive study on abnormalities associated with red blood cells in Saudi adult patients
por: Alsagaby, Suliman A.
Publicado: (2022)

Investigating the impact of RNA integrity variation on the transcriptome of human leukemic cells
por: Alsagaby, Suliman A.
Publicado: (2022)

In Silico Drug Screening Analysis against the Overexpression of PGAM1 Gene in Different Cancer Treatments
por: Fareed, Muhammad Mazhar, et al.
Publicado: (2021)

Lenalidomide and Chronic Lymphocytic Leukemia
por: González-Rodríguez, Ana Pilar, et al.
Publicado: (2013)

Proteomics-Based Regression Model for Assessing the Development of Chronic Lymphocytic Leukemia
por: Bakhtina, Varvara I., et al.
Publicado: (2021)

Transcriptomics-Based Investigation of Molecular Mechanisms Underlying Apoptosis Induced by ZnO Nanoparticles in Human Diffuse Large B-Cell Lymphoma
por: Alsagaby, Suliman A
Publicado: (2022)

Persistence of Anti-SARS-CoV-2 Spike IgG Antibodies Following COVID-19 Vaccines
por: Alharbi, Naif Khalaf, et al.
Publicado: (2022)

Bioactive phytoconstituents as potent inhibitors of casein kinase-2: dual implications in cancer and COVID-19 therapeutics
por: Anjum, Farah, et al.
Publicado: (2022)

Immunoglobulin Gene Repertoire in Chronic Lymphocytic Leukemia: Insight into Antigen Selection and Microenvironmental Interactions
por: Kostareli, Efterpi, et al.
Publicado: (2012)

New Insights into Biology, Prognostic Factors, and Current Therapeutic Strategies in Chronic Lymphocytic Leukemia
por: Smolewski, Piotr, et al.
Publicado: (2013)

Haematological and radiological-based prognostic markers of COVID-19
por: Alsagaby, Suliman A., et al.
Publicado: (2021)

Update in the management of chronic lymphocytic leukemia
por: Maddocks, Kami J, et al.
Publicado: (2009)

Targeted treatment for chronic lymphocytic leukemia
por: Masood, Aisha, et al.
Publicado: (2011)

Therapeutic advancement of chronic lymphocytic leukemia
por: Lu, Kang, et al.
Publicado: (2012)

Apoptosis inducers in chronic lymphocytic leukemia
por: Billard, Christian
Publicado: (2013)

Novel agents for chronic lymphocytic leukemia
por: Wu, Mei, et al.
Publicado: (2013)

Cardiac Involvement in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
por: Robak, Tadeusz, et al.
Publicado: (2022)

Allogeneic Transplantation for Chronic Lymphocytic Leukemia
por: Laurenti, Luca, et al.
Publicado: (2010)

Lenalidomide in the Treatment of Chronic Lymphocytic Leukemia
por: Cortelezzi, Agostino, et al.
Publicado: (2012)

Infectious Complications in Chronic Lymphocytic Leukemia
por: Nosari, Annamaria
Publicado: (2012)

Advances in treating chronic lymphocytic leukemia
por: Tausch, Eugen, et al.
Publicado: (2014)

Autoimmune Cytopenias in Chronic Lymphocytic Leukemia
por: D'Arena, Giovanni, et al.
Publicado: (2013)

Idelalisib for the Treatment of Chronic Lymphocytic Leukemia
por: Khan, Maliha, et al.
Publicado: (2014)

Infections in patients with chronic lymphocytic leukemia
por: Guarana, Mariana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oprlvd7i86g57rqj3oamqg113t